• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Amorphical Confirms Efficacy In Long-Term Phase 2 Crohn`s Trial

    PR NEWSWIRE

    Amorphical Enrolls First Patient In Phase 2 Trial

    PR NEWSWIRE

    Amorphical Reports Positive Interim Data In Ongoing Crohn Disease

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.